文献速递神经介入DSA

颅内动脉粥样硬化相关闭塞的血管成形与支架植入再灌注策略比较

Angioplasty, stenting, or both - rescue maneuvers and reperfusion after endovascular therapy for intracranial atherosclerosis-related occlusion.
PubMed 文献 · Neuroradiology · 2023-01-07

该回顾性多中心研究分析了124例颅内动脉粥样硬化相关闭塞患者的130次再灌注尝试,比较单纯血管内治疗、球囊血管成形、自膨式支架及球囊联合支架四种策略。结果显示球囊联合支架是最终成功再灌注的独立预测因素,且与90天良好预后独立相关,自膨式支架术后症状性颅内出血频率最高但死亡率无差异。

要点

  • 球囊联合支架是ICARO患者成功再灌注的独立预测因素。
  • 成功再灌注与90天良好预后独立相关。
  • 自膨式支架症状性颅内出血率最高,但死亡率无差异。

核心结论

  • 在ICARO患者中,补救性血管成形联合支架植入有效提高成功再灌注几率,且不增加颅内出血风险。
  • 球囊联合支架是最终成功再灌注的唯一独立预测因素,并与90天良好预后显著相关。

研究设计与样本

  • 回顾性分析三家高容量卒中中心前瞻性维护的血管内取栓注册数据库,纳入2015年1月至2019年12月连续ICARO患者。
  • 共分析124例ICARO患者(中位年龄70岁,范围61-80岁;男性76例)和130次再灌注尝试。
  • ICARO定义为任何固定高度狭窄(>70%)或任意程度狭窄伴持续再闭塞倾向。
  • 再灌注策略分为四组:血管内治疗(36次)、球囊血管成形(38次)、自膨式支架(17次)、球囊联合自膨式支架或球囊扩张支架(39次)。

关键影像表现/征象

  • 各组间死亡率无显著差异。

诊断标准与关键数值

  • 成功再灌注定义为mTICI 2b-3,总体达到71%(92/130)。
  • 良好预后定义为mRS 0-2,总体达到42%(52/124)。

临床应用与阅片要点

  • 对于ICARO患者,球囊联合支架可作为补救策略以提高成功再灌注率。
  • 使用自膨式支架时需警惕症状性颅内出血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Data concerning reperfusion strategies of intracranial atherosclerosis-related occlusion (ICARO) and clinico-angiographic outcomes remain scarce, particularly in Caucasians. We aim to compare the reperfusion rate and functional outcome between reperfusion strategies in the setting of the ICARO.

METHODS: Retrospective analysis of prospectively maintained endovascular thrombectomy (EVT) registries at three high-volume stroke centers were retrospectively analyzed for consecutive ICARO patients from January 2015 to December 2019. We defined ICARO as any fixed high-degree (> 70%) focal narrowing or stenosis of any degree with a perpetual tendency for reocclusion. We categorized reperfusion strategies into four groups: EVT [group 1], balloon angioplasty [(BAp), group 2], placement of self-expandable stents [(SES), group 3], and BAp combined with implantation of SES; or direct placement of balloon mounted stents (BMS) [(BAp-SES/BMS), group 4]. We evaluated the association with the successful reperfusion [mTICI 2b - 3] and favorable outcome [mRS 0-2] with logistic regression analysis.

RESULTS: Out of 2550 EVT, 124 patients (median age, 70 (61-80) years; 76 men) with ICARO and 130 reperfusion attempts [36 EVT, 38 BAp, 17 SES, and 39 BAp + SES/BMS] were analyzed. SES implantation showed the highest frequency of post-procedural symptomatic intracranial hemorrhage [(18%, 3/17), p = .03]; however, we observed no significant differences in the mortality rate. Overall, we achieved successful reperfusion in 71% (92/130) and favorable outcomes in 42% (52/124) of the patients. BAp + SES/BMS was the only independent predictor of the final successful reperfusion [aOR, 4.488 (95% CI, 1.364-14.773); p = .01], which was significantly associated with the 90-day favorable outcome [aOR, 10.837 (95% CI, 3.609-32.541); p = < .001] after adjustment for confounding variables between the reperfusion strategies.

CONCLUSION: Among patients with ICARO, the rescue angioplasty stenting effectively contributed to higher odds of successful reperfusion with no increased risk for intracranial hemorrhage.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Abdelrady, Rodriguez, Dargazanli, et al. Angioplasty, stenting, or both - rescue maneuvers and reperfusion after endovascular therapy for intracranial atherosclerosis-related occlusion. Neuroradiology. 2023. PMID: 36609714. doi:10.1007/s00234-022-03108-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。